Protective-2 (bpi-2358-106): A confirmatory trial to demonstrate superiority of the plinabulin plus pegfilgrastim (plin/peg) combination versus standard of care pegfilgrastim for the prevention of chemotherapy-induced neutropenia (cin) in breast cancer (bc) patients (pts) Blayney, D. W., Huang, L., Mohanlal, R. W. AMER ASSOC CANCER RESEARCH. 2021

View details for Web of Science ID 000618737700049